Drawing for RAVEX

USPTO serial 86688146

RAVEX

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
AWRICH, ELLEN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with RAVEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jordan A. LaVine

JORDAN A. LAVINE Flaster Greenberg P C1600 JFK Blvd Fl 2Philadelphia, PA 19103-2852UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Computer software for capturing, managing and reporting data and information in the fields of medical clinical trials and medical research, for designing, managing, and executing medical clinical trials and medical research and medical clinical trial and medical research protocols, for forecasting and benchmarking budgets and costs in medical clinical trials and medical research, for medical coding in medical clinical trials and medical research, for the collection of information and data in medical clinical trials and medical research, for evaluating and measuring the performance and results of medical clinical trials and medical research, for managing, organizing and reporting the results of medical clinical trials and medical research, for monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and medical research, for medical clinical trial and medial research user and learning management, for medical clinical trial and medical research operational reporting and analytics, and for medical clinical trial and medical research patient randomization and supply management; downloadable software in the nature of a mobile application for use in capturing, managing, and reporting data and information in the field of medical clinical trials and research; downloadable software in the nature of a mobile application for use in medical clinical trials, research monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and researchACTIVE—
042Software as a service (saas) solutions featuring software for capturing, managing and reporting data and information in the fields of medical clinical trials and medical research, for designing, managing, and executing medical clinical trials and medical research and medical clinical trial and medical research protocols, for forecasting and benchmarking budgets and costs in medical clinical trials and medical research, for medical coding in medical clinical trials and medical research, for the collection of information and data in medical clinical trials and medical research, for evaluating and measuring the performance and results of medical clinical trials and medical research, for capturing, managing, organizing and reporting the results of medical clinical trials and medical research, for monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and medical research, for medical clinical trial and medial research user and learning management, for medical clinical trial and medical research operational reporting and analytics, and for medical clinical trial and medical research patient randomization and supply management. providing temporary use of online non-downloadable computer software for capturing, managing and reporting data and information in the fields of medical clinical trials and medical research, for designing, managing, and executing medical clinical trials and medical research and medical clinical trial and medical research protocols, for forecasting and benchmarking budgets and costs in medical clinical trials and medical research, for medical coding in medical clinical trials and medical research, for the collection of information and data in medical clinical trials and medical research, for evaluating and measuring the performance and results of medical clinical trials and medical research, for managing, organizing and reporting the results of medical clinical trials and medical research, for monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and medical research, for medical clinical trial and medical research user and learning management, for medical clinical trial and medical research operational reporting and analytics, and for medical clinical trial and medical research patient randomization and supply managementACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 21, 2017MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 21, 2017ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 20, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 18, 2017EX2GSOU EXTENSION 2 GRANTED—
Jan 18, 2017EXT2SOU EXTENSION 2 FILED—
Jan 18, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 20, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 18, 2016EX1GSOU EXTENSION 1 GRANTED—
Jul 18, 2016EXT1SOU EXTENSION 1 FILED—
Jul 18, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 19, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 24, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 24, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 4, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 20, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 20, 2015DOCKASSIGNED TO EXAMINER—
Jul 15, 2015MPMKNOTICE OF PSEUDO MARK E-MAILED—
Jul 14, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 13, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance